2024-09-18 - Analysis Report
## PFE Stock Analysis:

**Company Overview:** Pfizer Inc. (PFE) is a multinational pharmaceutical corporation that develops and manufactures medicines and vaccines for a wide range of diseases. 

**1. Performance vs. S&P 500:**

* **PFE Cumulative Return:** -25.47%
* **VOO (S&P 500) Cumulative Return:** 88.56%
* **Performance Gap:** -114.03% 
    * PFE has significantly underperformed the S&P 500 over the period considered. The current relative divergence of 3.01 indicates that PFE is in the lower 3rd percentile of its historical performance compared to the S&P 500. 

**2. Recent Price Movement:**

* **Closing Price:** $29.72
* **5-day Moving Average:** $29.58
* **20-day Moving Average:** $29.03
* **60-day Moving Average:** $29.05

PFE's price has been relatively stable recently, with the 5-day moving average slightly above the other moving averages. This suggests some potential for further upside movement in the short term.

**3. Technical Indicators:**

* **RSI:** 60.27 
    * The RSI is above 50, indicating the stock is in a bullish territory. However, it is not extremely high, suggesting there may be room for further price growth.
* **PPO:** 0.44
    * The PPO is positive, indicating that the price momentum is bullish.
* **Delta_Previous_Relative_Divergence:** 1.38 
    * The recent relative divergence is positive, suggesting a potential for short-term upward price movement.
* **Expected Return:** 0.0%
    * This indicates no expected return over a 5-year period for a current investment.

**4. Recent Earnings and Outlook:**

| Date | EPS | Expected EPS |
|---|---|---|
| 2024-07-30 | 0.6 | 0.458 |
| 2024-05-01 | 0.82 | 0.516 |
| 2024-01-30 | 0.1 | -0.19 |
| 2023-10-31 | -0.17 | -0.32 |
| 2023-08-01 | 0.67 | 0.56 |

* **Most Recent Earnings (2024-07-30):** PFE exceeded analysts' expectations for the quarter, reporting EPS of 0.6 against an expected EPS of 0.458. This suggests the company is performing well and may continue to exceed expectations in the future.

**5. Overall Analysis:**

PFE is currently underperforming the broader market, but recent positive earnings results and bullish technical indicators suggest a potential for a turnaround. The company is showing strong earnings performance, exceeding expectations in the latest quarter. While the expected return is currently low, the potential for future growth remains, especially considering the strong recent earnings performance. However, investors should carefully consider the long-term performance gap against the S&P 500 before making any investment decisions.

**6. Report Summary:**

**Pfizer Inc. (PFE) Stock Analysis:**

PFE has significantly underperformed the S&P 500 in the past. However, recent price movements and technical indicators suggest potential for a bullish trend in the short term. The company is demonstrating strong earnings performance, exceeding expectations in the latest quarter. While the expected return is low, the potential for future growth remains. Investors should carefully consider the long-term performance gap against the S&P 500 before making any investment decisions. 
